The pharmaceutical industry faces escalating risks from sophisticated fraud schemes, including counterfeit drug distribution, billing irregularities, and corporate malfeasance. Forensic ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Drugmakers Pay More Than $8B in Fraud Fines in Past Decade The largest drugmakers in America have paid at least $8 billion in fines for repeated Medicare and Medicaid fraud in the past 10 years, but ...

A W. R. Berkley Corp. unit won a ruling from New Jersey’s high court affirming the insurer is off the hook for a pharmaceutical company’s legal defense costs in a dispute where a director was accused ...

Five pharmaceutical companies have paid more than $25 million to North Carolina to settle fraud allegations, thanks to investigations by the state’s Medicaid Investigations Unit, according to a news ...

Pharmaceutical manufacturer AstraZeneca, based in Wilmington, Del., has agreed to pay $520 million to settle allegations that it had illegally marketed its antipsychotic drug Seroquel, according to an ...

NEW YORK, March 3, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Inovio Pharmaceuticals, Inc. (NASDAQ: INO). Shareholders who purchased shares of INO during ...

Teva Pharmaceuticals will pay $27 million to settle allegations of Medicaid fraud revealed by a whistleblower, according to a news release from Florida Attorney General Bill McCollum. Ven-A-Care, a ...

A Texas pharmaceutical marketer has been sentenced and will now pay the United States government $59 million in reparations. The sentence comes after a lengthy court battle that put Californian ...

LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or ...

-- Who: Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) -- What: Securities fraud class action lawsuit filed -- Class Period: August 3, 2023, through December 26, 2025 -- Deadline to seek lead plaintiff ...

INO investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false ...